Global Drug Discovery Outsourcing Market Growth at 7.6% CAGR (2022–2030)
According to Straits Research, the global drug discovery outsourcing market size was valued at $3.29 billion in 2021. It is projected to reach $6.37 billion by 2030, growing at a CAGR of 7.6% during the forecast period (2022–2030).
Market Overview
The drug discovery outsourcing market is witnessing significant growth as pharmaceutical and biotech companies increasingly rely on third-party service providers to accelerate drug development. This approach enhances efficiency, reduces costs, and leverages specialized expertise, enabling companies to focus on core research and development.
Key Market Drivers
Increasing RD Costs: High costs associated with in-house drug discovery drive the demand for outsourcing solutions.
Technological Advancements: Adoption of AI, big data, and machine learning in drug discovery enhances efficiency.
Rising Prevalence of Chronic Diseases: Growing demand for innovative therapies fuels market expansion.
Expanding Biopharmaceutical Sector: The rise of biologics and personalized medicine boosts outsourcing activities.
Regulatory Pressures: Outsourcing helps companies comply with stringent regulatory requirements.
Key Developments in the Market
Strategic Partnerships Acquisitions: Companies are forming alliances to expand their drug discovery capabilities.
Increased Investment in AI and Automation: Advanced technologies are streamlining drug discovery processes.
Expansion of CRO Services: Contract research organizations (CROs) are enhancing their service offerings to cater to growing demand.
Focus on Biologics and Gene Therapy: Companies are investing in cutting-edge biopharmaceutical research.
Download Free Sample Report with Complimentary Analyst Consultation : https://straitsresearch.com/report/drug-discovery-outsourcing-market/request-sample
Leading Companies in the Drug Discovery Outsourcing Market
1. Curia
2. EVOTEC
3. Laboratory Corporation of America Holdings
4. GenScript
5. Pharmaceutical Product Development LLC
6. Charles River Laboratories
7. Thermo Fischer Scientific Inc.
8. Merck Co. Inc.
9. Oncodesign
10. Jubilant Biosys
11. Qiagen and Discover Corporation
Market Segmentation
By Workflow
1. Target Identification Screening
2. Target Validation Functional Informatics
3. Lead Identification Candidate Optimization
4. Preclinical Development
5. Other Associated Workflow
By Therapeutic Area
6. Respiratory System
7. Pain and Anesthesia
8. Oncology
9. Ophthalmology
10. Hematology
11. Cardiovascular
12. Endocrine
13. Gastrointestinal
14. Immunomodulation
15. Anti-Infective
16. Central Nervous System
17. Dermatology
18. Genitourinary System
By Drug Type
19. Small Molecules
20. Large Molecules (Biopharmaceuticals)
Conclusion
The drug discovery outsourcing market is poised for strong growth, driven by increasing RD investments, advanced technologies, and a growing need for cost-effective drug development. As pharmaceutical companies seek to optimize their research processes, outsourcing solutions will play a crucial role in shaping the future of drug discovery.
Why Straits Research?
Straits Research provides in-depth market intelligence, offering businesses actionable insights to navigate industry trends and market dynamics. Our comprehensive reports deliver precise data to help companies make informed decisions.
Contact Us:
Email: sales@straitsresearch.com
Phone: +1 646 905 0080 (US), +91 8087085354 (India), +44 203 695 0070 (UK)
Address: 825 3rd Avenue, New York, NY, USA, 10022
